Uveal Melanoma: all 281 studies

Page 3 of 3. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.

• Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal MelanomaActive, not recruitingNCT02068586Phase 2
• Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and CisplatinTerminatedNCT02029690Phase 1
• Dendritic Cells Plus Autologous Tumor RNA in Uveal MelanomaCompletedNCT01983748Phase 3
• Vascular Response to Brachytherapy Using Functional OCTCompletedNCT01955941
• Definity for Ultrasound of Intraocular TumorsWithdrawnNCT01930968
• BAP1 Testing in Instance Choroidal Nevi or Uveal MelanomaStatus unknownNCT01925599
• New Biopsy Technique for Uveal MelanomaCompletedNCT01924923
• Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular MelanomaCompletedNCT01893099Phase 1
• Clinical and Histopathologic Characteristics of BAP1 MutationsCompletedNCT01773655
• Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver MetastasesTerminatedNCT01730157Early Phase 1
• Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to LiverNo longer availableNCT01728051
• Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic MelanomaCompletedNCT01665183Phase 1
• Vorinostat in Treating Patients With Metastatic Melanoma of the EyeActive, not recruitingNCT01587352Phase 2
• A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal MelanomaCompletedNCT01551459Phase 2
• Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal MelanomaCompletedNCT01460810Not applicable
• Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma PatientsCompletedNCT01430416Phase 1
• A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal MelanomaStatus unknownNCT01377025Phase 2
• THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced DiseaseCompletedNCT01355120Phase 2
• Influence of Oral Treatment with Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas with Proton Beam TherapyCompletedNCT01338389Not applicable
• Study of Circulating Tumoral DNA in Metastatic Choroidal MelanomaCompletedNCT01334008Not applicable
• Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal MelanomaWithdrawnNCT01328106Phase 2
• Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal MelanomaCompletedNCT01253759
• Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the EyeStatus unknownNCT01217398Phase 2
• Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib MesylateCompletedNCT01046487Phase 1
• Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal MelanomaCompletedNCT01034787Phase 2
• Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaCompletedNCT01005472Phase 1
• A Study to Assess PV-10 Chemoablation of Cancer of the LiverStatus unknownNCT00986661Phase 1
• Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the EyeCompletedNCT00952939
• Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma PatientsTerminatedNCT00929019Phase 1/2
• Bone Marrow and Blood Samples From Patients With Metastatic Choroid MelanomaCompletedNCT00897624
• Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal MelanomaStatus unknownNCT00872391Not applicable
• Treatment Of Radiation Retinopathy TrialStatus unknownNCT00811200Phase 2/3
• Ranibizumab in Combination With Proton Beam Irradiation for Choroidal MelanomaCompletedNCT00765921Phase 1
• Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT00757614
• Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal MelanomaCompletedNCT00750399Phase 1
• Vaccine Therapy in Treating Patients With Advanced MelanomaCompletedNCT00705640Phase 1
• Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the EyeWithdrawnNCT00621439Not applicable
• Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque RadiotherapyStatus unknownNCT00540930Phase 4
• Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
• Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular MelanomaStatus unknownNCT00489944Phase 2
• Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00471471Phase 1
• Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by ElectroporationCompletedNCT00471133Phase 1
• Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal MelanomaStatus unknownNCT00459849Not applicable
• Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal MelanomaStatus unknownNCT00406900
• Validation of a Molecular Prognostic Test for Eye MelanomaWithdrawnNCT00406120
• Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning AloneCompletedNCT00351728
• Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 BrachytherapyTerminatedNCT00346372
• Cytogenetic Study of Ocular MelanomaCompletedNCT00344799
• Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00334776Phase 2
• Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaCompletedNCT00324727Phase 3
• Dendritic Cell Vaccination During Lymphoid ReconstructionCompletedNCT00313508Phase 1
• Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic MelanomaCompletedNCT00288041Phase 2
• PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT00238329Phase 2
• Study of Metastatic Ocular MelanomaStatus unknownNCT00168870Phase 2
• Pain Relief - Tramadol Versus IbuprofenStatus unknownNCT00111046Phase 1/2
• Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye MelanomaTerminatedNCT00110123Phase 3
• Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerCompletedNCT00096083Phase 2
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV MelanomaCompletedNCT00089219Phase 1/2
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00089206Phase 2
• Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for MelanomaCompletedNCT00089063Phase 2
• Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular MelanomaCompletedNCT00085306Phase 2
• Vaccine Therapy in Treating Patients With Stage IIC-IV MelanomaCompletedNCT00085189Phase 2
• Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV MelanomaCompletedNCT00072345Phase 2
• A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular MelanomaCompletedNCT00062933Phase 2
• Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00058279Phase 1/2
• Vaccine Therapy in Treating Patients With Melanoma of the EyeTerminatedNCT00036816Phase 3
• Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00032045Phase 2
• Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With MelanomaCompletedNCT00031733Phase 2
• Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00027742Phase 2
• Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During SurgeryCompletedNCT00025181Phase 1
• MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00020579Phase 1
• Vaccine Therapy in Treating Patients With Metastatic Melanoma of the EyeCompletedNCT00020475Phase 2
• Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1
• Vaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaTerminatedNCT00005841Phase 1
• Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005815Phase 1/2
• Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye MelanomaCompletedNCT00003802Phase 2
• Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003597Phase 1
• Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003339Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerCompletedNCT00003022Phase 1
• Indium In 111 Pentetreotide in Treating Patients With Refractory CancerTerminatedNCT00002947Phase 1
• Collaborative Ocular Melanoma Study (COMS)Status unknownNCT00000124Phase 3

← Uveal Melanoma overview